Saubadu S
Laboratoires Lederlé, Rungis.
Encephale. 1991 Dec;17 Spec No 3:435-9.
This multicentric study carried out in 1987 in 6 University hospital Centers enabled the comparison, under double blind conditions, of the antidepressant efficacy of amoxapine with that of clomipramine. For the planning, the design and the documentation of this study, the BLIPS/BDP (Biometric Laboratory Information Processing System/Banca Dati Psicofarmacologia) at the CCPDD (Center for Clinical Psychopharmacology Data Documentation) from the Institute of Psychiatry of the Pisa University was used. A total number of 108 patients, who fulfilled the DSM III criteria for major depressive episode, were treated (54 by amoxapine, and 54 by clomipramine). The results have shown: 1) The antidepressant activity of amoxapine was at least comparable to that of clomipramine. 2) The onset of action of amoxapine was quicker than that of clomipramine. 3) Amoxapine is well tolerated and the frequency of unwanted effects is lower compared to that of clomipramine.
1987年在6所大学医院中心开展的这项多中心研究,在双盲条件下对比了阿莫沙平与氯米帕明的抗抑郁疗效。为了这项研究的规划、设计和记录,使用了比萨大学精神病学研究所临床精神药理学数据文档中心的BLIPS/BDP(生物统计学实验室信息处理系统/精神药理学数据库)。共有108名符合重度抑郁发作DSM III标准的患者接受了治疗(54名使用阿莫沙平,54名使用氯米帕明)。结果显示:1)阿莫沙平的抗抑郁活性至少与氯米帕明相当。2)阿莫沙平的起效时间比氯米帕明快。3)阿莫沙平耐受性良好,与氯米帕明相比,不良反应的发生率更低。